Loading...
menu
Search
AI Trading Bot
Features
Markets
News
Resources
Pricing
Get Started
Home
ETF
ABVX
ABVX
-
Add to Watchlist
$
0.000
0.000
(
0.000%
)
At close
0.000
(
0.000%
)
Aft-market
ET
$
0.000
0.000
(
0.000%
)
At close
0.000
(
0.000%
)
Aft-market
ET
Overview
Technical
News
ABVX News
Biotech Sector Approaches Critical Phase 2 Milestones
2d ago
Newsfilter
ABIVAX Reports Increased Losses in Q1 Financial Results
4d ago
NASDAQ.COM
Abivax Q1 Financial Report Highlights
6d ago
seekingalpha
Abivax Reports Q1 2026 Financial Results and Interim Data from Study 108
May 22 2026
Newsfilter
Analysis of Biotech Companies' Prospects
May 22 2026
NASDAQ.COM
Investment Potential Analysis of Biotech Stocks
May 22 2026
Fool
European Tech Stocks Surge Amid AI Boom
May 21 2026
CNBC
HighVista Strategies Cuts Stake in Viridian Therapeutics by $7 Million
May 17 2026
Yahoo Finance
Abivax Announces Royalty Certificate Buyback and $45 Million ADS Offering
May 05 2026
NASDAQ.COM
Abivax Announces Royalty Certificate Repurchase and $45M ADS Offering
May 05 2026
Newsfilter
Abivax Stock Potential and Risks Analysis
Apr 07 2026
Fool
Abivax's Promising Drug Candidate Faces Risks Amid Market Volatility
Apr 07 2026
NASDAQ.COM
Investment Outlook for Healthcare Stocks
Mar 26 2026
Fool
Biotech Companies Show Promising Clinical Progress
Mar 26 2026
NASDAQ.COM
Abivax CEO: No Rush for Deals Ahead of Key Trial
Mar 24 2026
seekingalpha
Abivax Reports €530.4M Cash Position for 2025
Mar 23 2026
seekingalpha
Show More News
